Status:
COMPLETED
Impact of Aerobic Exercise on Immune Response and Side Effects of Cancer Treatments
Lead Sponsor:
Université de Sherbrooke
Conditions:
Colorectal Cancer Stage IV
Eligibility:
All Genders
50-65 years
Phase:
NA
Brief Summary
Aerobic exercise is associated with many benefits in patients with cancer treatments. Among these, the reduction of cancer-related fatigue (CRF) is one of the best demonstrated. Besides, several anima...
Eligibility Criteria
Inclusion
- Diagnosis of metastatic colorectal cancer
- At the beginning of their chemotherapy treatment
- Eastern Cooperative Oncology Group (ECOG) performance status between grades 0 to 1
- Physically capable to realise HIIT and continous moderate aerobic exercise on ergocycle
Exclusion
- Orthopedic, cardiac or metabolic limitations preventing aerobic effort
- Betablockers
- Surgery planned for the next two months following recruitment
Key Trial Info
Start Date :
November 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 4 2022
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04715061
Start Date
November 4 2020
End Date
October 4 2022
Last Update
November 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Centre on Aging
Sherbrooke, Quebec, Canada, J1H 4C4